170 related articles for article (PubMed ID: 1406291)
1. Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats.
Kashiwagi A; Obata T; Suzaki M; Takagi Y; Kida Y; Ogawa T; Tanaka Y; Asahina T; Ikebuchi M; Saeki Y
Metabolism; 1992 Oct; 41(10):1041-6. PubMed ID: 1406291
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
3. [Effects of vanadate on glucose metabolism of the streptozotocin-diabetic rat lens].
Endo M
Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):333-9. PubMed ID: 8317350
[TBL] [Abstract][Full Text] [Related]
4. Comparison of glucose, sorbitol and fructose accumulation in lens and liver of diabetic and insulin-treated rats and mice.
Gaynes BI; Watkins JB
Comp Biochem Physiol B; 1989; 92(4):685-90. PubMed ID: 2498032
[TBL] [Abstract][Full Text] [Related]
5. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
Tomlinson DR; Sidenius P; Larsen JR
Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
[TBL] [Abstract][Full Text] [Related]
6. [Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity].
Efimov AS; Obrosova IG; Velikiĭ NN
Probl Endokrinol (Mosk); 1984; 30(2):71-6. PubMed ID: 6425821
[TBL] [Abstract][Full Text] [Related]
7. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
8. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
10. Renal sorbitol, myo-inositol and glycerophosphorylcholine in streptozotocin-diabetic rats.
Schmolke M; Schleicher E; Guder WG
Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):607-14. PubMed ID: 1493153
[TBL] [Abstract][Full Text] [Related]
11. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
12. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: in vivo kinetic studies using 19F 3-FDG NMR in rats.
Kwee IL; Igarashi H; Nakada T
Neuroreport; 1996 Feb; 7(3):726-8. PubMed ID: 8733731
[TBL] [Abstract][Full Text] [Related]
14. Nerve glucose, sorbitol, fructose, and myo-inositol at various time after feeding in streptozotocin-induced diabetes in rats.
Dyck PJ; Minnerath SR; O'Brien PC
Mayo Clin Proc; 1989 Aug; 64(8):905-10. PubMed ID: 2796400
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes].
Kryvko IuIa; Kozyts'kyĭ ZIa; Serhiienko OO; Kuchmerovs'ka TM; Velykyĭ MM
Ukr Biokhim Zh (1999); 2001; 73(5):69-74. PubMed ID: 12035507
[TBL] [Abstract][Full Text] [Related]
16. Changes in sorbitol, myo-inositol and lipid inositol in dorsal root and sympathetic ganglia from streptozotocin-diabetic rats.
Llewelyn JG; Simpson CM; Thomas PK; King RH; Hawthorne JN
Diabetologia; 1986 Dec; 29(12):876-81. PubMed ID: 3569691
[TBL] [Abstract][Full Text] [Related]
17. Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats.
Shinohara R; Mano T; Nagasaka A; Sawai Y; Uchimura K; Hayashi R; Hayakawa N; Nagata M; Makino M; Kakizawa H; Itoh Y; Nakai A; Itoh M
Biochim Biophys Acta; 1998 Nov; 1425(3):577-86. PubMed ID: 9838221
[TBL] [Abstract][Full Text] [Related]
18. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
20. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Dines K; Love A
Diabetologia; 1992 Oct; 35(10):946-50. PubMed ID: 1451951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
